T. Rowe Price Associates’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.84B | Buy |
|
|||||
|
2025
Q1 | $11.2B | Sell |
|
|||||
|
2024
Q4 | $10.8B | Sell |
|
|||||
|
2024
Q3 | $14.6B | Sell |
|
|||||
|
2024
Q2 | $13.3B | Sell |
|
|||||
|
2024
Q1 | $12.9B | Buy |
|
|||||
|
2023
Q4 | $13.7B | Sell |
|
|||||
|
2023
Q3 | $13.5B | Sell |
|
|||||
|
2023
Q2 | $13.4B | Sell |
|
|||||
|
2023
Q1 | $14.9B | Sell |
|
|||||
|
2022
Q4 | $16.9B | Sell |
|
|||||
|
2022
Q3 | $16.6B | Sell |
|
|||||
|
2022
Q2 | $18.9B | Buy |
|
|||||
|
2022
Q1 | $16B | Sell |
|
|||||
|
2021
Q4 | $17.3B | Sell |
|
|||||
|
2021
Q3 | $13.8B | Buy |
|
|||||
|
2021
Q2 | $14B | Sell |
|
|||||
|
2021
Q1 | $13.9B | Sell |
|
|||||
|
2020
Q4 | $13.3B | Buy |
|
|||||
|
2020
Q3 | $11.3B | Buy |
|
|||||
|
2020
Q2 | $10.2B | Buy |
|
|||||
|
2020
Q1 | $8.39B | Buy |
|
|||||
|
2019
Q4 | $8.15B | Buy |
|
|||||
|
2019
Q3 | $5.29B | Sell |
|
|||||
|
2019
Q2 | $6.88B | Sell |
|
|||||
|
2019
Q1 | $9.31B | Sell |
|
|||||
|
2018
Q4 | $9.8B | Buy |
|
|||||
|
2018
Q3 | $10B | Sell |
|
|||||
|
2018
Q2 | $9.33B | Buy |
|
|||||
|
2018
Q1 | $8B | Buy |
|
|||||
|
2017
Q4 | $7.98B | Sell |
|
|||||
|
2017
Q3 | $7.2B | Buy |
|
|||||
|
2017
Q2 | $6.38B | Buy |
|
|||||
|
2017
Q1 | $5.47B | Buy |
|
|||||
|
2016
Q4 | $5.27B | Sell |
|
|||||
|
2016
Q3 | $4.66B | Buy |
|
|||||
|
2016
Q2 | $4.68B | Sell |
|
|||||
|
2016
Q1 | $4.71B | Sell |
|
|||||
|
2015
Q4 | $4.43B | Buy |
|
|||||
|
2015
Q3 | $4.21B | Buy |
|
|||||
|
2015
Q2 | $4.12B | Buy |
|
|||||
|
2015
Q1 | $3.62B | Buy |
|
|||||
|
2014
Q4 | $3.03B | Sell |
|
|||||
|
2014
Q3 | $3B | Sell |
|
|||||
|
2014
Q2 | $2.97B | Sell |
|
|||||
|
2014
Q1 | $3.41B | Buy |
|
|||||
|
2013
Q4 | $2.75B | Buy |
|
|||||
|
2013
Q3 | $2.29B | Sell |
|
|||||
|
2013
Q2 | $2.13B | Buy |
|